» Articles » PMID: 38509320

Revolutionizing Brain Interventions: the Multifaceted Potential of Histotripsy

Overview
Journal Neurosurg Rev
Specialty Neurosurgery
Date 2024 Mar 21
PMID 38509320
Authors
Affiliations
Soon will be listed here.
Abstract

Histotripsy, a non-thermal ultrasound technique, holds significant promise in various applications within the realm of brain interventions. While its use for treating brain tumors is somewhat limited, focused ultrasound technology has been extensively investigated for a wide range of purposes within the brain, including disrupting the blood-brain barrier, supporting immunotherapy, addressing conditions like essential tremor, Parkinson's disease, Alzheimer's disease, epilepsy, and neuropathic pain. Research findings indicate that histotripsy can reduce tumor cells with fewer pulses, minimizing the risk of bleeding and cellular injury. The use of MRI sequences such as T2 and T2* enhances the evaluation of the effects of histotripsy treatment, facilitating non-invasive assessment of treated areas. Furthermore, histotripsy displays promise in creating precise brain lesions with minimal edema and inflammation, particularly in porcine models, suggesting considerable progress in the treatment of brain lesions. Moreover, studies confirm its feasibility, safety, and effectiveness in treating intracerebral hemorrhage by safely liquefying clots without causing significant harm to surrounding brain tissue., opening exciting possibilities for clinical applications. The development of transcranial MR-guided focused ultrasound systems based on histotripsy represents a significant breakthrough in overcoming the limitations associated with thermal ablation techniques. Histotripsy's ability to efficiently liquefy clots, minimize skull heating, and target shallow lesions near the skull establishes it as a promising alternative for various brain treatments. In conclusion, histotripsy offers diverse potential in the field of brain interventions, encompassing applications ranging from tumor treatment to the management of intracerebral hemorrhage. While challenges such as accurate monitoring and differentiation of treatment effects persist, ongoing research efforts and technological advancements continue to expand the role of histotripsy in both neurology and neurosurgery.

Citing Articles

Advances in Tumor Management: Harnessing the Potential of Histotripsy.

Verma Y, Perera Molligoda Arachchige A Radiol Imaging Cancer. 2024; 6(3):e230159.

PMID: 38639585 PMC: 11148838. DOI: 10.1148/rycan.230159.

References
1.
Debela D, Muzazu S, Heraro K, Ndalama M, Mesele B, Haile D . New approaches and procedures for cancer treatment: Current perspectives. SAGE Open Med. 2021; 9():20503121211034366. PMC: 8366192. DOI: 10.1177/20503121211034366. View

2.
Muller C, Omari J, Mohnike K, Bar C, Pech M, Keitel V . Multidisciplinary Treatment of Patients with Progressive Biliary Tract Cancer after First-Line Gemcitabine and Cisplatin: A Single-Center Experience. Cancers (Basel). 2023; 15(9). PMC: 10177261. DOI: 10.3390/cancers15092598. View

3.
Ahmed M, Brace C, Lee Jr F, Goldberg S . Principles of and advances in percutaneous ablation. Radiology. 2011; 258(2):351-69. PMC: 6939957. DOI: 10.1148/radiol.10081634. View

4.
Ahmed M, Solbiati L, Brace C, Breen D, Callstrom M, Charboneau J . Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology. 2014; 273(1):241-60. PMC: 4263618. DOI: 10.1148/radiol.14132958. View

5.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View